Cns Pharmaceuticals Inc (NASDAQ:CNSP) currently has a daily average trading volume of 13.62M but it saw 70694871 shares traded in last market. With a market cap of 4.87M USD, the company’s current market price of $0.15 came rising about 3.26 while comparing to the previous closing price of $0.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $137.50 and as low as $0.10. In the recent trading on the day, stock has struck highest price mark of $0.14 while lowest mark touched by it was $0.185.
Taking a look at 20-day trading activity of Cns Pharmaceuticals Inc (CNSP) gives us an average price of $0.1283, while its current price level is -99.89% below from 52-week high level whereas it is 52.46% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1431 while that of 200 days or SMA-200 reads an average of $8.5777. A closer look into the stock’s movement over the week reveals that its volatility is standing at 47.40% during that period while stretching the period over a month that decreases to 17.55%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.26 which implies that the stock is in neutral territory.
Over the week, CNSP’s stock price is moving 21.54% up while it is 2.18% when we observe its performance for the past one month. Year-to-date it is -99.77% down and over the past year, the stock is showing a downside performance of -99.88%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -2.1 beat the consensus estimate of -3.3 for the same. The company is expected to be releasing its next quarterly report on 2024-Nov-13, for which analysts forecasted an EPS of -0.1 while estimate for next year EPS is -0.85.
Currently, Cns Pharmaceuticals Inc’s total number of outstanding shares is 33.45M with 1.85% of that held by the insiders while 0.45% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1018.78%. Stock’s beta reads 1.04. Its return on asset (ROA) is -358.12% on average.
